Unicycive Therapeutics Inc (UNCY)’s price-to-cash and price-to-free cash flow ratios

The price of Unicycive Therapeutics Inc (NASDAQ: UNCY) closed at $1.38 in the last session, down -2.13% from day before closing price of $1.41. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 980019 shares were traded. UNCY stock price reached its highest trading level at $1.4300 during the session, while it also had its lowest trading level at $1.3650.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.



We take a closer look at UNCY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.76 and its Current Ratio is at 0.76.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNCY now has a Market Capitalization of 47.96M and an Enterprise Value of 39.07M. For the stock, the TTM Price-to-Sale (P/S) ratio is 70.54. Its current Enterprise Value per Revenue stands at 57.88 whereas that against EBITDA is -1.29.

Stock Price History:

Over the past 52 weeks, UNCY has reached a high of $2.29, while it has fallen to a 52-week low of $0.47. The 50-Day Moving Average of the stock is 1.3226, while the 200-Day Moving Average is calculated to be 0.9457.

Shares Statistics:

According to the various share statistics, UNCY traded on average about 335.54K shares per day over the past 3-months and 307.26k shares per day over the past 10 days. A total of 34.76M shares are outstanding, with a floating share count of 24.99M. Insiders hold about 28.10% of the company’s shares, while institutions hold 39.19% stake in the company. Shares short for UNCY as of Mar 15, 2024 were 56.73k with a Short Ratio of 0.17, compared to 97.96k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.16% and a Short% of Float of 0.20%.

Earnings Estimates

The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.18, while EPS last year was -$0.97. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.09 and low estimates of -$0.15.

Analysts are recommending an EPS of between -$0.24 and -$0.6 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.02, with 3 analysts recommending between $0.35 and -$0.25.

Revenue Estimates

Based on 3 analysts’ estimates, the company’s revenue will be $36.25M in the next fiscal year. The high estimate is $84.73M and the low estimate is $2.02M. The average revenue growth estimate for next year is up 1,350.00% from the average revenue estimate for this year.

Most Popular